IRS 990 Nonprofit Profile
Advancing Cancer Treatment
Acts mission is to make the washington, dc metropolitan area a leader in advancing clinical trial accrual, thus accelerating improved cancer care and treatment.
- Filing year
- 2024
- Total revenue
- $43K
- Total expenses
- $824K
- Program expenses
- $786K
- Administration
- $37K
- Fundraising
- $2K
- Program share of expenses
- 95%
- EIN
- 832886283
- Location
- Moultonborough, NH
About CharitySense
CharitySense provides live, independent intelligence from the charitable infrastructure you fund — hospitals, schools, orphanages, and clinics anywhere in the world.
See live projects or read our insights on nonprofit accountability.
Financial data on this page is sourced from IRS Form 990 filings.